The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

Proposed cuts to Medicaid will have significant impacts on the health industry. One area that will be heavily impacted by ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement ...

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring ...

Under terms of the deal, Alchemab will lead early Phase I trials for ATLX-1282 in amyotrophic lateral sclerosis, while Lilly ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...